RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2023

Jun 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2023-06-21

Reporting Person: Arbuckle Stuart A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-21	Stock Option (right to buy)	$18.47	A	14000	Acquired	2033-06-20	Common Stock (14000)	Direct
2023-06-21	Restricted Stock Units	$	A	3000	Acquired		Common Stock (3000)	Direct

Footnotes

F1: The options fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date.

F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3: The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.